Real-time enrollment status for this chronic spinal cord injury clinical trial
Current Status
Recruiting
Checked: November 15, 2026 at 2:54 PM UTC
| NCT Number | NCT07799532 |
| Recruiting Status | Recruiting |
| Condition | Chronic Spinal Cord Injury |
| Phase | PHASE3 |
| Target Enrollment | 150 participants |
| Active Locations | 21 sites in the US |
| Sponsor | NervGen Pharma |
| Last Updated on CT.gov | November 6, 2026 (1 week ago) |
As of November 15, 2026: Clinical trial NCT07799532 is currently recruiting participants. This phase3 study for chronic spinal cord injury is actively seeking new participants at 21 locations across the United States. The study is sponsored by NervGen Pharma. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07799532 is actively recruiting participants as of November 15, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 21 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07799532 was last updated 1 week ago (November 6, 2026). HelloStudys verifies this status automatically.